Form 8-K - Current report:
SEC Accession No. 0001558370-24-013882
Filing Date
2024-10-30
Accepted
2024-10-30 07:07:35
Documents
14
Period of Report
2024-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20241030x8k.htm   iXBRL 8-K 34415
2 EX-99.1 bpmc-20241030xex99d1.htm EX-99.1 144473
  Complete submission text file 0001558370-24-013882.txt   309903

Data Files

Seq Description Document Type Size
3 EX-101.SCH bpmc-20241030.xsd EX-101.SCH 3300
4 EX-101.LAB bpmc-20241030_lab.xml EX-101.LAB 15243
5 EX-101.PRE bpmc-20241030_pre.xml EX-101.PRE 9842
16 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20241030x8k_htm.xml XML 4719
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 241407426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)